???global.info.a_carregar???
Andreia Neves Carvalho main research focus is on the characterization of the molecular mechanisms underlying mitochondrial dysfunction, oxidative and endoplasmic reticulum stress and associated neuro-axonal damage leading to neurodegeneration. In this context she is interested in the research of new molecular mechanisms involved in the regulation of mitochondrial function, at the level of mitochondrial biogenesis and mitochondrial dynamics, namely through post-translational modifications of key proteins involved in these processes, in order to pursue new potential therapeutic targets and strategies for the treatment of neurodegenerative diseases. Andreia Neves Carvalho got her PhD in Pharmacy - Biochemistry in 2012 by the University of Lisbon. She then worked as a post-doctoral fellow at the Department of Molecular Cell Biology and Immunology of the VU University Medical Centre, Amsterdam, The Netherlands. During this period she was the recipient of a DuPré Grant from Multiple Sclerosis International Federation (MSIF) and an ECTRIMS Postdoctoral Research Fellowship from European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). She moved back to Portugal and is currently a Junior Researcher at iMed.ULisboa, Faculty of Pharmacy, University of Lisbon.
Identificação

Identificação pessoal

Nome completo
Andreia Margarida Gonçalves das Neves Carvalho

Nomes de citação

  • Carvalho, Andreia N
  • Neves Carvalho, A

Identificadores de autor

Ciência ID
A813-6CDE-641A
ORCID iD
0000-0001-9605-5054
Researcher Id
ISU-9035-2023
Scopus Author Id
55194180800

Endereços de correio eletrónico

  • amcarvalho@ff.ulisboa.pt (Profissional)

Moradas

  • iMED.ULisboa - Research Institute for Medicines, Faculty of Pharmacy, University of Lisbon. Av. Prof. Gama Pinto, 1649-003 , Lisboa, Lisboa, Portugal (Profissional)

Websites

Domínios de atuação

  • Ciências Naturais - Ciências Biológicas - Bioquímica
  • Ciências Médicas e da Saúde - Medicina Básica - Neurociências

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Português (Idioma materno)
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Holandês Utilizador elementar (A2) Utilizador independente (B1) Utilizador independente (B1) Utilizador independente (B1)
Alemão Utilizador elementar (A1) Utilizador elementar (A1) Utilizador elementar (A1) Utilizador elementar (A1)
Formação
Grau Classificação
2023
Concluído
CONGENTO Course on Modules 9, 10 and 11 according to the EC Common Education and Training Framework ("Upgrade Course" on Laboratory Animal Sciences) (Pós-Graduação)
Fundação Champalimaud, Portugal

Instituto Gulbenkian de Ciência, Portugal
2022
Concluído
Post-graduate course "Characterisation of post-translational modifications in cellular signalling" (Pós-Graduação)
Syddansk Universitet, Dinamarca
2020
Concluído
Post-graduate Course on Laboratory Animal Sciences (FELASA B) (Pós-Graduação)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2012/10
Concluído
Pharmacy (Doutoramento)
Especialização em Biochemistry
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Role of Glutathione S-Transferase pi in Neuronal Protection under Oxidative Stress and Proteasome Inhibition - Relevance to Parkinson's Disease" (TESE/DISSERTAÇÃO)
Distinção e Louvor
2006/07
Concluído
Biochemistry (Licenciatura)
Universidade de Lisboa Faculdade de Ciências, Portugal
"Study of the variations of expression of the gene Gstp and of apoptosis genes, induced by MPTP, in mice brain" (TESE/DISSERTAÇÃO)
16/20
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento
Empregador
2019/03/01 - Atual Investigador (Investigação) Universidade de Lisboa Faculdade de Farmácia, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2014/11/01 - 2019/02/28 Pós-doutorado (Investigação) Universidade de Lisboa Faculdade de Farmácia, Portugal

Outros

Categoria Profissional
Instituição de acolhimento
Empregador
2013/09/01 - 2014/10/31 Post-doctoral fellow with an ECTRIMS Postdoctoral Research Fellowship from European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) VU Medisch Centrum, Países Baixos
VU Medisch Centrum, Países Baixos
2013/01/01 - 2013/04/30 Post-doctoral fellow VU Medisch Centrum, Países Baixos
2012/11/01 - 2012/12/31 Post-doctoral fellow, with a DuPré Grant from Multiple Sclerosis International Federation (MSIF) VU Medisch Centrum, Países Baixos
2008/05/01 - 2012/10/04 PhD student - PhD fellowship from FCT/ Bolseira de Doutoramento Universidade de Lisboa Faculdade de Farmácia, Portugal
2007/05/01 - 2008/04/30 Scientific Investigation Fellow / Bolseira de Investigação Universidade de Lisboa Faculdade de Farmácia, Portugal
2006/09/01 - 2007/04/30 Scientific Investigation Fellow / Bolseira de Investigação Universidade de Coimbra Faculdade de Medicina, Portugal
Projetos

Bolsa

Designação Financiadores
2022/01 - 2023/12 REMIND - REdox-signaling modulation of MItochoNdrial Dysfunction through post-translational modifications
EXPL/BIA-BQM/0793/2021
Investigador responsável
Fundação para a Ciência e a Tecnologia
Concluído
2018 - 2021 PGC-1alpha Isoforms as novel Therapeutic targets in ParkinsON's Disease
PTDC/MED-FSL/30104/2017
Investigador
Universidade de Lisboa Faculdade de Farmácia, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2018 - 2021 TITANIC - CYP46A1 as a new TherapeutIcTArget in NIemann-Pick type C disease
PTDC/MED-NEU/29455/2017
Investigador
Fundação para a Ciência e a Tecnologia
Concluído
2013/06 - 2015/11 S-Glutathionylation in Parkinson´s Disease.
Bolseiro de Pós-Doutoramento
Fundação para a Ciência e a Tecnologia
Concluído
2013/06 - 2015/11 Unraveling the neuroprotective role of TUDCA in Parkinson´s disease: targeting oxidative stress and mitophagy
Bolseiro de Pós-Doutoramento
Fundação para a Ciência e a Tecnologia
Concluído
2013 - 2014 Mitochondrial dynamics in multiple sclerosis
n.a.
Bolseiro de Pós-Doutoramento
VU Medisch Centrum, Países Baixos
European Committee for Treatment and Research in Multiple Sclerosis
Concluído
2013 - 2013 Protective effects of endogenous antioxidants in Multiple Sclerosis
061112
Investigador
VU Medisch Centrum, Países Baixos
Hersenstichting
Concluído
2005/07 - 2008/04 Evaluation of the protective role of Glutathione S-Transferase pi against MPTP neurotoxicity
Bolseiro de Doutoramento
Fundação para a Ciência e a Tecnologia
2005/09 - 2007/12 What HIF? Degradation is better than growth in preventing angiogenesis in diabetic retinopathy
Bolseiro de Investigação
Fundação para a Ciência e a Tecnologia
Concluído
Produções

Publicações

Artigo em revista
  1. Sandra I. Anjo; Zhicheng He; Zohaib Hussain; Aruba Farooq; Alan McIntyre; Charles A. Laughton; Andreia Neves Carvalho; Mattéa J. Finelli. "Protein Oxidative Modifications in Neurodegenerative Diseases: From Advances in Detection and Modelling to Their Use as Disease Biomarkers". Antioxidants (2024): https://doi.org/10.3390/antiox13060681.
    10.3390/antiox13060681
  2. Nunes, Maria João; Carvalho, Andreia Neves; Reis, Joana; Costa, Daniela; Moutinho, Miguel; Mateus, Joana; Mendes de Almeida, Rita; et al. "Cholesterol redistribution triggered by CYP46A1 gene therapy improves major hallmarks of Niemann-Pick type C disease but is not sufficient to halt neurodegeneration". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1870 3 (2024): 166993. http://dx.doi.org/10.1016/j.bbadis.2023.166993.
    10.1016/j.bbadis.2023.166993
  3. Nunes, M.J.; Carvalho, A.N.; Sá-Lemos, C.; Colaço, M.; Cervenka, I.; Ciraci, V.; Santos, S.G.; et al. "Sustained PGC-1a2 or PGC-1a3 expression induces astrocyte dysfunction and degeneration". European Journal of Cell Biology 103 1 (2024): 151377. http://dx.doi.org/10.1016/j.ejcb.2023.151377.
    10.1016/j.ejcb.2023.151377
  4. Caria, Inês; Nunes, Maria João; Ciraci, Viviana; Carvalho, Andreia Neves; Ranito, Catarina; Santos, Susana G.; Gama, Maria João; et al. "NPC1-like phenotype, with intracellular cholesterol accumulation and altered mTORC1 signaling in models of Parkinson's disease". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1870 2 (2024): 166980. http://dx.doi.org/10.1016/j.bbadis.2023.166980.
    10.1016/j.bbadis.2023.166980
  5. Nunes, Maria João; Carvalho, Andreia Neves; Rosa, Alexandra I.; Videira, Paula A.; Gama, Maria João; Rodrigues, Elsa; Castro-Caldas, Margarida. "Altered expression of Sialyl Lewis X in experimental models of Parkinson's disease". Journal of Molecular Medicine (2024): http://dx.doi.org/10.1007/s00109-023-02415-3.
    10.1007/s00109-023-02415-3
  6. Romina A. Guedes; Jorge H. Grilo; Andreia N. Carvalho; Pedro M. P. Fernandes; Ana S. Ressurreição; Vanessa Brito; Adriana O. Santos; et al. "New Scaffolds of Proteasome Inhibitors: Boosting Anticancer Potential by Exploiting the Synergy of In Silico and In Vitro Methodologies". Pharmaceuticals (2023): https://doi.org/10.3390/ph16081096.
    10.3390/ph16081096
  7. Carvalho, Andreia N.; Branco, Vasco; van Horssen, Jack; Saso, Luciano. "Editorial: Redox-signaling in neurodegenerative diseases: biomarkers, targets, and therapies". Frontiers in Cellular Neuroscience 17 (2023): http://dx.doi.org/10.3389/fncel.2023.1198669.
    10.3389/fncel.2023.1198669
  8. Leonardo-Sousa, Carlota; Carvalho, Andreia Neves; Guedes, Romina A.; Fernandes, Pedro M. P.; Aniceto, Natália; Salvador, Jorge A. R.; Gama, Maria João; Guedes, Rita C.. "Revisiting Proteasome Inhibitors: Molecular Underpinnings of Their Development, Mechanisms of Resistance and Strategies to Overcome Anti-Cancer Drug Resistance". Molecules 27 7 (2022): 2201. http://dx.doi.org/10.3390/molecules27072201.
    10.3390/molecules27072201
  9. Klionsky, Daniel J.; Abdel-Aziz, Amal Kamal; Abdelfatah, Sara; Abdellatif, Mahmoud; Abdoli, Asghar; Abel, Steffen; Abeliovich, Hagai; et al. "Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)". Autophagy 17 1 (2021): 1-382. http://dx.doi.org/10.1080/15548627.2020.1797280.
    10.1080/15548627.2020.1797280
  10. Mendes, Mariana Oliveira; Rosa, Alexandra Isabel; Carvalho, Andreia Neves; Nunes, Maria João; Dionísio, Pedro; Rodrigues, Elsa; Costa, Daniela; et al. "Neurotoxic effects of MPTP on mouse cerebral cortex: Modulation of neuroinflammation as a neuroprotective strategy". Molecular and Cellular Neuroscience 96 (2019): 1-9. http://dx.doi.org/10.1016/j.mcn.2019.01.003.
    10.1016/j.mcn.2019.01.003
  11. Rosa, Alexandra Isabel; Duarte-Silva, Sara; Silva-Fernandes, Anabela; Nunes, Maria João; Carvalho, Andreia Neves; Rodrigues, Elsa; Gama, Maria João; et al. "Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease". 55 12 (2018): 9139-9155.
    10.1007/s12035-018-1062-4
  12. Moreira, Sara; Fonseca, Inês; Nunes, Maria João; Rosa, Alexandra; Lemos, Luísa; Rodrigues, Elsa; Carvalho, Andreia Neves; et al. "Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease". Experimental Neurology 295 (2017): 77-87. http://dx.doi.org/10.1016/j.expneurol.2017.05.009.
    10.1016/j.expneurol.2017.05.009
  13. Rosa, Alexandra I.; Fonseca, Inês; Nunes, Maria João; Moreira, Sara; Rodrigues, Elsa; Carvalho, Andreia Neves; Rodrigues, Cecília M.P.; Gama, Maria João; Castro-Caldas, Margarida. "Novel insights into the antioxidant role of tauroursodeoxycholic acid in experimental models of Parkinson's disease". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1863 9 (2017): 2171-2181. http://dx.doi.org/10.1016/j.bbadis.2017.06.004.
    10.1016/j.bbadis.2017.06.004
  14. Neves Carvalho, Andreia; Firuzi, Omidreza; Joao Gama, Maria; van Horssen, Jack; Saso, Luciano. "Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?". Current Drug Targets 18 6 (2017): 705-718. http://dx.doi.org/10.2174/1389450117666160401120514.
    10.2174/1389450117666160401120514
  15. Carvalho, Andreia Neves; Marques, Carla; Guedes, Rita C.; Castro-Caldas, Margarida; Rodrigues, Elsa; van Horssen, Jack; Gama, Maria João. "S-Glutathionylation of Keap1: a new role for glutathione S-transferase pi in neuronal protection". FEBS Letters 590 10 (2016): 1455-1466. http://dx.doi.org/10.1002/1873-3468.12177.
    10.1002/1873-3468.12177
  16. Carvalho, Andreia N; Lim, Jamie L; Nijland, Philip G; Witte, Maarten E; Van Horssen, Jack. "Glutathione in multiple sclerosis: More than just an antioxidant?". Multiple Sclerosis Journal 20 11 (2014): 1425-1431. http://dx.doi.org/10.1177/1352458514533400.
    10.1177/1352458514533400
  17. Carvalho, Andreia Neves; Marques, Carla; Rodrigues, Elsa; Henderson, Colin J.; Wolf, C. Roland; Pereira, Paulo; Gama, Maria João. "Ubiquitin-Proteasome System Impairment and MPTP-Induced Oxidative Stress in the Brain of C57BL/6 Wild-type and GSTP Knockout Mice". Molecular Neurobiology 47 2 (2012): 662-672. http://dx.doi.org/10.1007/s12035-012-8368-4.
    10.1007/s12035-012-8368-4
  18. Castro-Caldas, M.; Carvalho, A. Neves; Rodrigues, E.; Henderson, C. J.; Wolf, C. R.; Rodrigues, C. M. P.; Gama, M. J.. "Tauroursodeoxycholic Acid Prevents MPTP-Induced Dopaminergic Cell Death in a Mouse Model of Parkinson’s Disease". Molecular Neurobiology 46 2 (2012): 475-486. http://dx.doi.org/10.1007/s12035-012-8295-4.
    10.1007/s12035-012-8295-4
  19. Castro-Caldas, Margarida; Carvalho, Andreia Neves; Rodrigues, Elsa; Henderson, Colin; Wolf, C. Roland; Gama, Maria João. "Glutathione S-Transferase pi Mediates MPTP-Induced c-Jun N-Terminal Kinase Activation in the Nigrostriatal Pathway". Molecular Neurobiology 45 3 (2012): 466-477. http://dx.doi.org/10.1007/s12035-012-8266-9.
    10.1007/s12035-012-8266-9
  20. Castro-Caldas, Margarida; Carvalho, Andreia Neves; Peixeiro, Isabel; Rodrigues, Elsa; Lechner, Maria Celeste; Gama, Maria Joao. "GSTpi Expression in MPTP-Induced Dopaminergic Neurodegeneration of C57BL/6 Mouse Midbrain and Striatum". Journal of Molecular Neuroscience 38 2 (2009): 114-127. http://hdl.handle.net/10451/21153.
    Publicado • http://dx.doi.org/10.1007/s12031-008-9141-z
Tese / Dissertação
  1. Carvalho, Andreia Margarida Gonçalves das Neves, 1982-. "Role of glutathione s-transferase pi in neuronal protection under oxidative stress and proteasome inhibition relevance to Parkinson’s disease". Doutoramento, 2012. http://hdl.handle.net/10451/7425.
Atividades

Orientação

Título / Tema
Papel desempenhado
Curso (Tipo)
Instituição / Organização
2022 - Atual CYP46A1-dependent regulation of neuronal intracellular traffic
Coorientador
Farmácia
Universidade de Lisboa Faculdade de Farmácia, Portugal
2022 - 2023 Antioxidant and anti-inflammatory potential of polyphenols and derived metabolites in Parkinson's disease
Orientador
Universidade de Lisboa Faculdade de Farmácia, Portugal
2022 - 2023 Redox regulation of mitochondrial dynamics and function in Parkinson's disease
Orientador
Universidade de Lisboa Faculdade de Farmácia, Portugal
2021 - 2022 S-glutathionylation of mitofusin 2 in the regulation of mitochondrial (dys)function in Parkinson´s Disease
Orientador
2020 - 2021 Signaling Pathways and players activated upon neuronal mitochondrial dysfunction and involved in antioxidant response - specific role of PGC-1a isoforms
Coorientador
Universidade de Lisboa Faculdade de Farmácia, Portugal
2018 - 2019 Small molecule PGC-1alpha activators: a novel class of anti-neurodegenerative therapeutics
Coorientador
Mestrado em Ciências Biofarmacêuticas (Mestrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2016 - 2017 Interplay of Endoplasmic Reticulum Stress and Autophagy in Parkinson's Disease
Coorientador
Genética Molecular e Biomedicina (Mestrado)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2013 - 2014 The role of glutathione in Multiple Sclerosis
Orientador
Master Programme in Neurobiology (Mestrado)
Universiteit van Amsterdam, Países Baixos

Organização de evento

Nome do evento
Tipo de evento (Tipo de participação)
Instituição / Organização
2019 - 2019 11th International Meeting of Portuguese Society for Stem Cells and Cell Therapy (2019) (Member of the organizing committee) (2018 - 2019/10)
Congresso (Membro da Comissão Organizadora)
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2010 - 2010 2nd Post-Graduate iMED.UL Students Meeting (2010) (Member of the organizing committee) (2010 - 2010)
Simpósio (Membro da Comissão Organizadora)
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Participação em evento

Descrição da atividade
Tipo de evento
Nome do evento
Instituição / Organização
2021 - 2025 COST action CA20121 Bench to Bedside transition for Pharmacological regulation of NRF2 in non-communicable diseases
Outro
2009 - 2024 International Brain Awareness Week (Science and Society Outreaching Activity) Participation in educational activities for the general public that include seminars/lectures, lab tours and classroom/school visits.
2020 - 2020 Descobre a ULisboa - Como manter o stress oxidativo afastado? O papel dos antioxidantes na saúde (Science and Society Outreaching Activity) Communication at interactive exhibition for students
Universidade de Lisboa Faculdade de Farmácia, Portugal
2019 - 2019 Científicamente Provável - O Cérebro e as Drogas (Science and Society Outreaching Activity) Educational activities for students
Universidade de Lisboa Faculdade de Farmácia, Portugal
2016 - 2016 Discovering the Brain! funded by the Dana Alliance for Brain Initiatives & Federation of European Neuroscience Societies (FENS) (Science and Society Outreaching Activity) Participation as a team member in the project. Coordinator: M Castro-Caldas
2013 - 2013 MS Research Days 2013, Hasselt, Belgium (Science and Society Outreaching Activity) The MS Research Days initiative consists in an annual meeting of people working in MS Research in The Netherlands and Belgium, where recent findings and current research in the area are presented and discussed not only with other researchers but also, and maybe more importantly, with MS patients
2012 - 2012 MS Research Days 2012, Doorwerth, The Netherlands (Science and Society Outreaching Activity) The MS Research Days initiative consists in an annual meeting of people working in MS Research in The Netherlands and Belgium, where recent findings and current research in the area are presented and discussed not only with other researchers but also, and maybe more importantly, with MS patients MS Research Days 2012

Júri de grau académico

Tema
Tipo de participação
Nome do candidato (Tipo de grau)
Instituição / Organização
2024 Testing new NRF2 activators in an AMD mouse model
Arguente principal
Shuvajit-Rakshit (Mestrado)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2023 Development of a screening pipeline to identify modulators of Nrf2 activity
Arguente principal
Margarida Isabel Lopes Pedro (Mestrado)
Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal
2022 Assess neurometabolic dysfunction and edit mitochondrial genome in the context of Leigh Syndrome by using induced pluripotent stem cell models
Arguente
Ricardo Barradas Pereira (Mestrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2022 The role of GSH signaling in mitophagy induced by reactive oxygen species: potential target for neuroprotection in stroke?
Arguente principal
Diana Sofia Ferreira Tavares (Mestrado)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2021 Exploring the neuroprotective role of miR-335 in experimental Parkinson's Disease
Arguente
Ana Cecília Moita do Rosário Lúcio (Mestrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2016 ER stress in Parkinson's Disease
Arguente
Miguel de Almeida Santos (Mestrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal

Arbitragem científica em revista

Nome da revista (ISSN) Editora
2023 - Atual Review Editor on the Editorial Board of Frontiers in Aging Neuroscience - speciality section Cellular and Molecular Mechanisms of Brain-Aging
2022/03/01 - Atual Review Editor on the Editorial Board of Frontiers in Pharmacology - Neuropharmacology Frontiers
2022 - Atual Review Editor on the Editorial Board of Frontiers in Neuroscience - Neuropharmacology Frontiers
2020 - Atual Member of the Reviewer Board of Cells (2073-4409) MDPI
2020 - Atual Member of the reviewer board of Antioxidants (2076-3921)
2023 - 2024 Guest Associate Editor - Antioxidants "Protein Oxidative Modification in Brain Function, Brain Ageing and Neurological Diseases"
2021 - 2023 Guest associate editor Research Topic Frontiers in Cellular Neuroscience - Cellular Neuropathology "Redox-Signalling in Neurodegenerative Diseases: Biomarkers, Targets, and Therapies" Frontiers

Curso / Disciplina lecionado

Disciplina Curso (Tipo) Instituição / Organização
2022 - 2024 PhD Advanced Course: Molecular Biomarkers and Technologies (Curso de doutoramento (conclusão de unidades curriculares)) Universidade de Lisboa Faculdade de Farmácia, Portugal
2021 - 2024 PhD Advanced Course: Redox Signaling and Redox System in Health and Disease (Curso de doutoramento (conclusão de unidades curriculares)) Universidade de Lisboa Faculdade de Farmácia, Portugal
2019 - 2024 Pharmacogenetics Master Course in Biopharmaceutical Sciences (MCBF) (Mestrado) Universidade de Lisboa Faculdade de Farmácia, Portugal
2021 - 2023 Cellular Biology Master Course in Pharmaceutical Sciences (MICF) (Mestrado integrado) Universidade de Lisboa Faculdade de Farmácia, Portugal
2021 - 2022 Experimental Design in Research and Innovation Master Course in Biopharmaceutical Sciences (MCBF) (Mestrado) Universidade de Lisboa Faculdade de Farmácia, Portugal
2018 - 2021 Biochemistry II Master Course in Pharmaceutical Sciences (MICF) (Mestrado integrado) Universidade de Lisboa Faculdade de Farmácia, Portugal
2015 - 2018 Eukaryotic gene regulation and functional genetics Master Course in Biopharmaceutical Sciences (MCBF) (Mestrado) Universidade de Lisboa Faculdade de Farmácia, Portugal
2014 - 2014 Allergy & Autoimmunity Biomedical Sciences and Health & Life Sciences (Bachelor) Vrije Universiteit Amsterdam, Países Baixos

Membro de comissão

Descrição da atividade
Tipo de participação
Instituição / Organização
2010 - 2011 Founding member of the iMED.UL Post-Graduate Students Commission (2010/2011)
Membro
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Distinções

Outra distinção

2022 Fellowship/ Travel grant to attend the EMBO practical course "Characterisation of post-translational modifications in cellular signalling" (Odense, Denmark 2022)
2015 Fellowship/Travel grant to attend the 31st ECTRIMS Congress (Spain 2015)
European Committee for Treatment and Research in Multiple Sclerosis, Suiça
2014 Fellowship - Young Scientist Program - 23rd IUBMB and 44th SBBq Congress (Brazil 2015)
International Union of Biochemistry and Molecular Biology, Canadá
2012 DuPré Grant
Multiple Sclerosis International Federation, Reino Unido
2012 ECTRIMS Postdoctoral Research Fellowship
European Committee for Treatment and Research in Multiple Sclerosis, Suiça